TTK Healthcare (BOM:507747) Cyclically Adjusted PB Ratio: (As of Sep. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:507747 TTK Healthcare Ltd BOM:507747
77 GF Score
Price ₹1,104.30
GF Value ₹1,442.08
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is TTK Healthcare Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


TTK Healthcare  (BOM:507747) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


TTK Healthcare Cyclically Adjusted PB Ratio Related Terms


TTK Healthcare Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for TTK Healthcare's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TTK Healthcare Cyclically Adjusted PB Ratio Chart

TTK Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.76 3.72 4.40 3.02 1.60

TTK Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 2.66 0.00 1.60 0.00

BOM:507747 vs LLY, JNJ, ABBV: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - General subindustry, TTK Healthcare's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TTK Healthcare Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTK Healthcare's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where TTK Healthcare's Cyclically Adjusted PB Ratio falls into.


BOM:507747
77GF Score
TTK Healthcare Ltd BOM:507747
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TTK Healthcare Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

TTK Healthcare's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, TTK Healthcare's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/167.3573*167.3573
=0.000

Current CPI (Jun. 2026) = 167.3573.

TTK Healthcare Quarterly Data

Book Value per Share CPI Adj_Book
201609 188.470 105.961 297.674
201612 0.000 105.196 0.000
201703 202.769 105.196 322.587
201706 0.000 107.109 0.000
201709 201.812 109.021 309.799
201712 0.000 109.404 0.000
201803 164.879 109.786 251.340
201806 0.000 111.317 0.000
201809 169.338 115.142 246.131
201812 0.000 115.142 0.000
201903 177.940 118.202 251.938
201906 0.000 120.880 0.000
201909 175.732 123.175 238.766
201912 0.000 126.235 0.000
202003 176.216 124.705 236.486
202006 0.000 127.000 0.000
202009 194.970 130.118 250.770
202012 0.000 130.889 0.000
202103 208.525 131.771 264.841
202106 0.000 134.084 0.000
202109 217.756 135.847 268.265
202112 0.000 138.161 0.000
202203 233.285 138.822 281.238
202206 0.000 142.347 0.000
202209 657.003 144.661 760.082
202212 0.000 145.763 0.000
202303 674.723 146.865 768.870
202306 0.000 150.280 0.000
202309 688.152 151.492 760.220
202312 0.000 152.924 0.000
202403 708.364 153.035 774.661
202406 0.000 155.789 0.000
202409 735.155 157.882 779.274
202412 0.000 158.323 0.000
202503 753.750 157.552 800.661
202506 0.000 159.755 0.000
202509 767.925 162.289 791.906
202512 0.000 163.281 0.000
202603 788.995 164.272 803.812
202606 0.000 167.357 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is TTK Healthcare (BOM:507747) Overvalued in 2026?

Based on GuruFocus' analysis, TTK Healthcare stock appears to be undervalued. The current stock price of ₹1,104.30 is trading 23.4% below its estimated GF Value™ of ₹1,442.08. GuruFocus considers TTK Healthcare to be Modestly Undervalued.

Key valuation signals for BOM:507747:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₹1,442.08 vs. price of ₹1,104.30 (23.4% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the BOM:507747 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TTK Healthcare Business Description

Other Exchanges TTKHLTCARE:India
Address No. 6, Cathedral Road, Chennai, TN, IND, 600 086
TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.
77GF Score

Get the complete analysis for BOM:507747

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,104.30
Price
₹1,442.08
GF Value